Le Lézard
Classified in: Health
Subjects: CHI, CSR

VWR Sales Team Helps Raise $12,000 for Duke Children's


RADNOR, Pa., Oct. 3, 2017 /PRNewswire/ -- VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, recently hosted its Faces of Research event for the second year bringing researchers from Duke University together with patients in the hospital for an interactive fundraiser.

VWR presented a $12,000 check to Duke Children's. The event honored the memory of Howell Brown III. (L to R): Jonathan Yoppi, VP of Segment Solutions for E&MR at VWR; Dr. Corinne Linardic, Associate Professor of Pediatrics at Duke Children's; Sue Brown, mother of Howell Brown III; Kristi Oristian, Pediatric Cancer Researcher at Duke Children's; Stacey Pope, Manager of Major Accounts for E&MR/Healthcare at VWR; Lynn Moore, Director of Region Sales for E&MR/Healthcare at VWR.

Stacey Pope, VWR's Manager of Major Accounts for Education & Medical Research (E&MR)/Healthcare in the Southeast U.S., gathered a group of employees from VWR's Sales team to organize and successfully promote the fundraiser for Duke Children's Hospital, which was held on their campus in Durham, NC, on September 29th.

Stacey, who is personally involved with the hospital, developed the event last year and commented, "I am thrilled we were able to host another successful event this year for Duke Children's. This event not only raises funds for the hospital, but also provides the patients a moment to forget their illness and enjoy being a child."

The 2017 Faces of Research event brought over 200 Duke researchers together with VWR employees and suppliers. During the event, the group formed small teams to run, climb and jump through a challenging obstacle course.  Each team selected and participated in honor of a specific patient at Duke Children's. Information packets were created for each team which included a personal story about the child they were competing on behalf of. The winning team earned a trophy, bragging rights and the opportunity to hand out medals to each child involved in the event.

Kristi Oristian, Pediatric Cancer Researcher for Duke Children's commented, "This event is a great opportunity for researchers to meet the individuals our research directly impacts. It turns science into a human experience."

Jonathan Yoppi, VWR's Vice President of Segment Solutions for E&MR, and Stacey proudly presented a $12,000 check to Duke Children's at the close of the event. The VWR Foundation, a charitable organization dedicated to giving back to the science community, will be donating an additional $1,700 on behalf of the 17 VWR employees who participated in the event.

About VWR 
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.5 billion in 2016, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 10,200 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

For more information on VWR please visit www.vwr.com.

Media Contact:
Valerie Collado
Director, Corporate Communications
VWR 
484.885.9338
[email protected]

VWR International, LLC Logo. (PRNewsFoto/VWR International, LLC)

SOURCE VWR


These press releases may also interest you

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...



News published on and distributed by: